设为首页 加入收藏

Ireland[爱尔兰药品]

Ulcid 20 mg gastro-resistant capsulesOmeprazole
TableofContents 1.NAMEOFTHEMEDICINALPRODUCT 2.QUALITATIVEANDQUANTITATIVECOMPOSITION 3.PHARMACEUTICALFORM 4.CLINICALPARTICULARS 4.1Therapeuticindications 4.2Posologyandmethodofadminis..
录入者:admin       发表于:2013-07-23            查阅全文...
GLIADEL 7.7 MG IMPLANTCarmustine
TableofContents 1.NAMEOFTHEMEDICINALPRODUCT 2.QUALITATIVEANDQUANTITATIVECOMPOSITION 3.PHARMACEUTICALFORM 4.CLINICALPARTICULARS 4.1Therapeuticindications 4.2Posologyandmethodofadministration ..
录入者:admin       发表于:2013-07-20            查阅全文...
Janumet 50 mg/850 mg film-coated tabletsMetformin Hydrochlor
TableofContents 1.NAMEOFTHEMEDICINALPRODUCT 2.QUALITATIVEANDQUANTITATIVECOMPOSITION 3.PHARMACEUTICALFORM 4.CLINICALPARTICULARS 4.1Therapeuticindications 4.2Posologyandmethodofadmin..
录入者:admin       发表于:2013-07-14            查阅全文...
Janumet 50 mg/1,000 mg film-coated tabletsMetformin Hydrochl
TableofContents 1.NAMEOFTHEMEDICINALPRODUCT 2.QUALITATIVEANDQUANTITATIVECOMPOSITION 3.PHARMACEUTICALFORM 4.CLINICALPARTICULARS 4.1Therapeuticindications 4.2Posologyandmethodofadmin..
录入者:admin       发表于:2013-07-14            查阅全文...
NovoNorm 0.5 mg tabletsNovoNorm 1 mg tabletsNovoNorm 2 mg ta
TableofContents 1.NAMEOFTHEMEDICINALPRODUCT 2.QUALITATIVEANDQUANTITATIVECOMPOSITION 3.PHARMACEUTICALFORM 4.CLINICALPARTICULARS 4.1Therapeuticindications 4.2Posologyandmethodofadmin..
录入者:admin       发表于:2013-07-13            查阅全文...
BYDUREON 2 mg powder and solvent for prolonged-release suspe
TableofContents 1.NAMEOFTHEMEDICINALPRODUCT 2.QUALITATIVEANDQUANTITATIVECOMPOSITION 3.PHARMACEUTICALFORM 4.CLINICALPARTICULARS 4.1Therapeuticindications 4.2Posologyandmethodofadmin..
录入者:admin       发表于:2013-07-13            查阅全文...
DIAMICRON MR 30 mg, modified release tablet.Gliclazide
TableofContents 1.NAMEOFTHEMEDICINALPRODUCT 2.QUALITATIVEANDQUANTITATIVECOMPOSITION 3.PHARMACEUTICALFORM 4.CLINICALPARTICULARS 4.1Therapeuticindications 4.2Posologyandmethodofadmin..
录入者:admin       发表于:2013-07-13            查阅全文...
Leukeran 2mg Film-coated TabletsChlorambucil
TableofContents 1.NAMEOFTHEMEDICINALPRODUCT 2.QUALITATIVEANDQUANTITATIVECOMPOSITION 3.PHARMACEUTICALFORM 4.CLINICALPARTICULARS 4.1Therapeuticindications 4.2Posologyandmethodofadmin..
录入者:admin       发表于:2013-07-11            查阅全文...
Dopacard 10mg/mlConcentrate for solution for infusionDopexam
TableofContents 1.NAMEOFTHEMEDICINALPRODUCT 2.QUALITATIVEANDQUANTITATIVECOMPOSITION 3.PHARMACEUTICALFORM 4.CLINICALPARTICULARS 4.1Therapeuticindications 4.2Posologyandmethodofad..
录入者:admin       发表于:2013-07-10            查阅全文...
Zometa 4 mg/5 ml concentrate for solution for infusionZoledr
TableofContents 1.NAMEOFTHEMEDICINALPRODUCT 2.QUALITATIVEANDQUANTITATIVECOMPOSITION 3.PHARMACEUTICALFORM 4.CLINICALPARTICULARS 4.1Therapeuticindications 4.2Posologyandmethodofadmin..
录入者:admin       发表于:2013-07-10            查阅全文...
Zometa 4 mg/100 ml solution for infusionZoledronic acid
TableofContents 1.NAMEOFTHEMEDICINALPRODUCT 2.QUALITATIVEANDQUANTITATIVECOMPOSITION 3.PHARMACEUTICALFORM 4.CLINICALPARTICULARS 4.1Therapeuticindications 4.2Posologyandmethodofadmin..
录入者:admin       发表于:2013-07-10            查阅全文...
ADVAGRAF Cáps. dura de liberación prolongada 0,5 mg env. con
Claseterapéutica:Immunología Principiosactivos:Tacrolimús ATC:Tacrolimús Laboratorio:ASTELLASPHARMA Enfermedades:Tratamientosrechazoentrasplanterenal,prevenci..
录入者:admin       发表于:2013-07-04            查阅全文...
Advagraf 3 mg prolonged-release hard capsulesTacrolimus Mono
TableofContents 1.NAMEOFTHEMEDICINALPRODUCT 2.QUALITATIVEANDQUANTITATIVECOMPOSITION 3.PHARMACEUTICALFORM 4.CLINICALPARTICULARS 4.1Therapeuticindications 4.2Posologyandmethodofadmin..
录入者:admin       发表于:2013-07-04            查阅全文...
Advagraf 1 mg prolonged-release hard capsulesTacrolimus Mono
TableofContents 1.NAMEOFTHEMEDICINALPRODUCT 2.QUALITATIVEANDQUANTITATIVECOMPOSITION 3.PHARMACEUTICALFORM 4.CLINICALPARTICULARS 4.1Therapeuticindications 4.2Posologyandmethodofadmin..
录入者:admin       发表于:2013-07-04            查阅全文...
Advagraf 1 mg prolonged-release hard capsulesTacrolimus Mono
TableofContents 1.NAMEOFTHEMEDICINALPRODUCT 2.QUALITATIVEANDQUANTITATIVECOMPOSITION 3.PHARMACEUTICALFORM 4.CLINICALPARTICULARS 4.1Therapeuticindications 4.2Posologyandmethodofadmin..
录入者:admin       发表于:2013-07-04            查阅全文...
Advagraf 5 mg prolonged-release hard capsulesTacrolimus Mono
TableofContents 1.NAMEOFTHEMEDICINALPRODUCT 2.QUALITATIVEANDQUANTITATIVECOMPOSITION 3.PHARMACEUTICALFORM 4.CLINICALPARTICULARS 4.1Therapeuticindications 4.2Posologyandmethodofadmin..
录入者:admin       发表于:2013-07-04            查阅全文...
Advagraf 0.5 mg prolonged-release hard capsulesTacrolimus Mo
TableofContents 1.NAMEOFTHEMEDICINALPRODUCT 2.QUALITATIVEANDQUANTITATIVECOMPOSITION 3.PHARMACEUTICALFORM 4.CLINICALPARTICULARS 4.1Therapeuticindications 4.2Posologyandmethodofadmin..
录入者:admin       发表于:2013-07-04            查阅全文...
ELIGARD 45 mg, powder and solvent for solution for injection
TableofContents 1.NAMEOFTHEMEDICINALPRODUCT 2.QUALITATIVEANDQUANTITATIVECOMPOSITION 3.PHARMACEUTICALFORM 4.CLINICALPARTICULARS 4.1Therapeuticindications 4.2Posologyandmethodofadminis..
录入者:admin       发表于:2013-07-03            查阅全文...
ELIGARD 7.5 mg, powder and solvent for solution for injectio
TableofContents 1.NAMEOFTHEMEDICINALPRODUCT 2.QUALITATIVEANDQUANTITATIVECOMPOSITION 3.PHARMACEUTICALFORM 4.CLINICALPARTICULARS 4.1Therapeuticindications 4.2Posologyandmethodofadminis..
录入者:admin       发表于:2013-07-03            查阅全文...
ELIGARD 22.5 mg, powder and solvent for solution for injecti
TableofContents 1.NAMEOFTHEMEDICINALPRODUCT 2.QUALITATIVEANDQUANTITATIVECOMPOSITION 3.PHARMACEUTICALFORM 4.CLINICALPARTICULARS 4.1Therapeuticindications 4.2Posologyandmethodofadminis..
录入者:admin       发表于:2013-07-03            查阅全文...

相关栏目

热门文章

推荐文章

广告位